Megestrol acetate for treatment of anorexia‐cachexia syndrome


Anorexia‐cachexia syndrome (ACS) is a common clinical problem characterised by loss of appetite and weight loss. It is common in patients who suffer from advanced cancer, AIDS and some other conditions. At present, there is no cure for ACS.

Megestrol acetate (MA) is classified as a female hormone and is taken by mouth. It is currently used to improve appetite and to increase weight in ACS.

This updated review shows that:

MA improves appetite and has a small effect on weight gain;

MA does not improve quality of life;

side effects are more frequent in patients treated with MA.

This review shows that MA is associated with an increased risk of blood clots (which may result in swelling, pain or redness of one extremity and not the other, sudden difficulty in breathing, severe headache or vision changes), fluid retention (resulting in swelling of the feet or hands) and death.

In patients who take MA, approximately one in four will have an increase in their appetite, one in 12 will have an increase in their weight and one in 23 will die.

Limited data are available regarding the safety of using MA, especially in the long term.

Abstract

Background: This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate for the treatment of anorexia‐cachexia syndrome'. Megestrol acetate (MA) is currently used to improve appetite and to increase weight in cancer‐associated anorexia. In 1993, MA was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia or unexplained weight loss in patients with AIDS. The mechanism by which MA increases appetite is unknown and its effectiveness for anorexia and cachexia in neoplastic and AIDS (acquired immunodeficiency syndrome) patients is under investigation.

Objectives: To evaluate the efficacy, effectiveness and safety of MA in palliating anorexia‐cachexia syndrome in patients with cancer, AIDS and other underlying pathologies.

Search methods: We sought studies through an extensive search of electronic databases, journals, reference lists, contact with investigators and other search strategies outlined in the methods. The most recent search for this update was carried out in May 2012.

Selection criteria: Studies were included in the review if they assessed MA compared to placebo or other drug treatments in randomised controlled trials of patients with a clinical diagnosis of anorexia‐cachexia syndrome related to cancer, AIDS or any other underlying pathology.

Data collection and analysis: Two independent review authors conducted data extraction and evaluated methodological quality. We performed quantitative analyses using appetite and quality of life as a dichotomous variable, and analysed weight gain as continuous and dichotomous variables.

Main results: We included 35 trials in this update, the same number but not the same trials as in the previous version of the review. The trials comprised 3963 patients for effectiveness and 3180 for safety. Sixteen trials compared MA at different doses with placebo, seven trials compared different doses of MA with other drug treatments and 10 trials compared different doses of MA. Meta‐analysis showed a benefit of MA compared with placebo, particularly with regard to appetite improvement and weight gain in cancer, AIDS and other underlying conditions, and lack of benefit in the same patients when MA was compared to other drugs. There was insufficient information to define the optimal dose of MA, but higher doses were more related to weight improvement than lower doses. Quality of life improvement in patients was seen only when comparing MA versus placebo but not other drugs in both subcategories: cancer and AIDS. Oedema, thromboembolic phenomena and deaths were more frequent in the patients treated with MA. More than 40 side effects were studied.

Authors' conclusions: This review shows that MA improves appetite and is associated with slight weight gain in cancer, AIDS and in patients with other underlying pathology. Despite the fact that these patients are receiving palliative care they should be informed of the risks involved in taking MA.

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group.

Publication status: New search for studies and content updated (conclusions changed).

Citation: Ruiz Garcia V, López‐Briz E, Carbonell Sanchis R, Gonzalvez Perales JL, Bort‐Marti S. Megestrol acetate for treatment of anorexia‐cachexia syndrome. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD004310. DOI: 10.1002/14651858.CD004310.pub3.


Source: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0012691/

Friday, June 5, 2026

Pentoxifylline (Trental) - Blood Flow - Patient guide - What to expect

Using trental pentoxifylline safely depends on clear expectations, proper timing, and honest communication about side effects as they arise. Patients who engage actively with their treatment plan tend to report better experiences than those who treat prescription as passive event. It is commonly chosen for patients treating poor circulation that causes leg pain or cramping during activity. Benefit often builds with correct dosing and reasonable expectations rather than immediate dramatic change. Patients who track symptoms honestly usually give their clinician better information to guide later adjustments. Patients can review https://lucasclinic.com/blood-flow/trental-pentoxifylline/ for basic orientation before or after starting treatment. That material frames medicine inside real clinical decisions rather than generic advice, which helps patients separate routine experiences from things that actually need review. Most medication setbacks start with ordinary disruption. Travel, illness, added over the counter products, or inconsistent timing can all shift results in ways that confuse later analysis. Stable routines give clinicians cleaner data to work with. Patients should also remember that treatment sits inside circulation support, not in isolation. Sleep, diet, hydration, activity, and underlying conditions all shape how well plan works. Follow up visits should review whole pattern rather than one symptom in a vacuum. Safety planning should stay plain and direct. Patients should report dizziness, chest pain, arrhythmia, nausea that does not settle, or worsening pain despite continued use rather than hoping the body will work things out on its own. Fast communication often resolves medication related concerns much more easily than delayed ones. General guidance for this medication category is collected at https://lucasclinic.com/blood-flow/. That broader view can support more productive questions at the next visit and more realistic expectations while waiting for results. Patients rarely need a perfect routine, but they do need honest reporting, steady habits, and enough follow up to catch problems before they grow into larger disruptions that require more time to reverse.

Sunday, May 31, 2026

Sildenafil: The Generic Form Of Kamagra Explained

Sildenafil is the generic name of the medication sold under the brand name Kamagra. Generic medications contain the same active ingredient at the same dose and strength as their brand name counterparts and must meet the same FDA standards for quality, purity, and bioequivalence. The development and approval of generic drugs play an important role in making effective treatments more accessible and affordable for patients. The spectrum of allergic disease is broad. Seasonal allergic rhinitis, often called hay fever, flares in response to outdoor allergens such as tree pollen in spring and ragweed in fall. Perennial allergies occur year-round and are typically triggered by indoor allergens like dust mites and pet dander. Chronic urticaria manifests as persistent hives and can last months or years without a clearly identifiable cause. All of these conditions share a common inflammatory pathway driven by the immune system's release of chemical mediators. The pharmacological action of sildenafil is the basis for its use in treating conditions within the category of sexual health. Understanding the mechanism by which the active compound produces its therapeutic effects helps patients appreciate why the medication needs to be taken consistently and at the correct dose to achieve the best results. Switching between brand name and generic versions of a medication is generally considered safe when the products are bioequivalent, but patients should inform their doctor if they notice any differences in effect after a formulary change. Some patients with conditions requiring precise drug levels in the blood may be monitored more closely during transitions. For most patients, however, approved generics provide equivalent therapeutic benefit to the brand name product. The sexual health section on sexual health covers both brand name and generic treatment options, giving patients a complete picture of what is available. Cost, insurance coverage, and pharmacy availability are practical factors to discuss with a pharmacist when filling a prescription for sildenafil.

Wednesday, May 27, 2026

Managing Stress: Evidence-Based Approaches

Stress is a universal human experience, but chronic stress has significant negative consequences for both physical and mental health. Long-term activation of the body's stress response contributes to hypertension, cardiovascular disease, impaired immune function, metabolic dysfunction, sleep disruption, anxiety, depression, and cognitive impairment. Understanding effective strategies for managing stress empowers individuals to protect their health and improve their quality of life. The stress response is a biological system designed for short-term survival, preparing the body to respond to immediate threats through physiological changes including elevated heart rate, blood pressure, blood glucose, and heightened alertness. While adaptive in acute situations, chronic activation of this system without adequate recovery creates wear on body systems. Identifying personal stressors and developing strategies for managing them is the foundation of stress management. Mindfulness-based stress reduction, developed by Jon Kabat-Zinn, is one of the most evidence-supported psychological approaches to stress management. It involves cultivating non-judgmental present-moment awareness through regular meditation and mindful attention to daily activities. Research demonstrates its effectiveness in reducing perceived stress, anxiety, depression, and improving physical health outcomes including blood pressure and immune function. For patients whose chronic stress is contributing to health problems requiring medical attention and prescription support, care is accessible through https://www.amoxilcompharm.com/. Physical exercise is one of the most powerful and versatile stress management tools available. Aerobic exercise reduces stress hormones including cortisol and adrenaline, stimulates production of endorphins and other mood-elevating neurochemicals, improves sleep quality, and provides a healthy outlet for physical tension. Even a single bout of moderate exercise produces immediate mood-elevating effects. Consistent exercise practice builds psychological resilience. Social connection is a critical buffer against the health effects of stress. Maintaining meaningful relationships, investing time in community, and seeking support during difficult periods provide both emotional and physiological protective effects. Professional psychological support including cognitive behavioral therapy is highly effective for stress-related mental health conditions. For comprehensive stress management information and mental health resources, visit https://amoxicillina.online/ for evidence-based patient guidance.

Saturday, May 16, 2026

Alendronate (Fosamax) - Osteoporosis - Patient guide

Alendronate affordability can influence osteoporosis care when patients must sustain treatment over years. Direct pill cost matters, but indirect burden also matters: fracture anxiety, mobility loss, home-safety expenses, and urgent visits after falls all affect long-term stability. Better outcomes usually come from pairing affordability planning with consistent dosing and fall-prevention strategy. Before follow-up visits, patients can review alendronate treatment options and prepare refill questions. Useful planning includes insurance tier review, pharmacy comparison, refill quantity limits, calcium and vitamin D budget considerations, and expected monthly cost changes. Looking ahead before supply runs low can prevent treatment gaps that weaken long-term prevention strategy. Monitoring remains essential during cost-driven changes. Patients should track weekly dosing success, reflux symptoms, swallowing discomfort, exercise consistency, fall events, posture confidence, calcium intake, and new bone pain. Early reassessment after symptom change can reduce complications and improve adherence. Medication counseling should reinforce correct administration technique, upright posture after dosing, and urgent reporting of severe heartburn, swallowing pain, jaw symptoms, or pain after minor trauma. These signals can require quick review. Supportive habits still matter regardless of medication price. Weight-bearing activity when safe, home fall-prevention planning, hydration, nutrition support, and reduction of tobacco and excess alcohol use strengthen overall bone-health protection. Medication reconciliation at each visit helps identify interacting products and medicines that affect fracture risk or administration safety. Patients should bring complete lists of prescriptions, over-the-counter products, and supplements. For broader fracture-prevention planning and home-safety support, patients can use osteoporosis care resources and maintain written logs for clinic review. Reliable alendronate outcomes usually come from affordability planning, correct technique, and timely reassessment when warning signs appear. Patients who keep weekly dosing and symptom logs often catch administration problems earlier, helping clinicians refine bone-protection plans before fracture risk rises. Written administration reminders and follow-up checklists improve long-term adherence and safety.

Wednesday, May 13, 2026

Clonidine (clonidine): Uses, How It Works, And What To Expect

Clonidine is a medication used in the treatment of conditions falling under blood pressure management. Its active pharmaceutical ingredient is clonidine, which has been studied in clinical settings and has an established record of use in appropriate patient populations. Understanding what this medication does, how it is taken, and what results are realistic helps patients make informed decisions alongside their healthcare providers. Antihypertensive medications work through several different mechanisms, and many patients eventually require two or more drugs to achieve adequate blood pressure control. Major classes include ACE inhibitors and ARBs, which relax blood vessels by blocking the renin-angiotensin system; calcium channel blockers, which reduce arterial stiffness; beta-blockers, which slow the heart rate and reduce its workload; and diuretics, which reduce blood volume by increasing fluid excretion through the kidneys. The therapeutic action of clonidine is tailored to the biological mechanisms underlying the conditions it is used to treat. By targeting specific receptors, enzymes, or pathways, it produces changes that reduce symptoms and in some cases modify the course of disease. Detailed clinical information about Clonidine can be found at https://mednewwsstoday.com/blood-pressure/clonidine/, which outlines indications, dosing guidelines, and important safety information. Most patients tolerate Clonidine well, though like any medication it can cause side effects in some individuals. Common side effects are typically mild and may resolve once the body adjusts to the medication. Serious adverse effects are less common but should be reported to a healthcare provider promptly. Patients with specific health conditions or those taking multiple medications should review potential interactions before starting Clonidine. Resources covering the full range of therapies available for blood pressure management are available at blood pressure management. Comparing medications in terms of their effectiveness, safety, and practical considerations helps patients and caregivers engage in productive conversations with their healthcare team.

Sunday, May 10, 2026

Zyprexa: Dosage Guide And Timing Considerations

Taking medication correctly is just as important as choosing the right one. For Zyprexa (olanzapine), following the prescribed or recommended dosage schedule consistently is essential to achieving and maintaining therapeutic effects. The pharmacokinetic profile of olanzapine determines how quickly it is absorbed, how long it stays active in the body, and how often it needs to be taken. Treatment with antipsychotic medications requires careful monitoring and ongoing evaluation. Metabolic parameters including weight, blood glucose, and lipid levels should be tracked regularly, particularly for patients on atypical antipsychotics. Patients and caregivers should be educated about the importance of adherence, as abrupt discontinuation can lead to rapid symptom relapse. Treatment is often long-term for chronic psychotic conditions, and medication switches may be needed if the initial choice does not provide adequate symptom control or causes intolerable side effects. The standard dosing of Zyprexa varies depending on the condition being treated, the patient's age, weight, and kidney or liver function, and whether it is being used for acute symptom relief or chronic management. Full prescribing and dosage details, including dose adjustments for specific populations such as elderly patients or those with organ impairment, are available at https://mednewwsstoday.com/antipsychotics/zyprexa-olanzapine/. Consistency is key when taking Zyprexa. Skipping doses or stopping early can reduce the medication's effectiveness or, in some cases, allow the underlying condition to worsen. If a dose is missed, patients should generally take it as soon as they remember unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped. Doubling up to make up for a missed dose is not recommended for most medications. Those seeking comparative information on dosing and safety profiles across medications used for antipsychotic medications can refer to https://mednewwsstoday.com/antipsychotics/, where detailed profiles of individual medications in this category are maintained for patient education.

Tuesday, May 5, 2026

Trental For Lymphedema: A Patient Guide

Lymphedema is a condition that affects a significant number of people and can range from mild and occasional to persistent and severely disruptive. Understanding the available treatment options is an important part of managing symptoms effectively. Healthcare providers evaluate the severity of the condition and the patient's overall health profile before recommending a specific medication or combination of treatments. Allergic conditions affect hundreds of millions of people worldwide and range from mild seasonal symptoms to chronic conditions that persist throughout the year. The immune system's overreaction to harmless environmental substances such as pollen, dust mites, pet dander, and certain foods drives most allergic disease. Histamine, released by immune cells when they detect an allergen, is the primary chemical mediator responsible for the familiar symptoms of sneezing, runny nose, itchy eyes, and skin reactions. Trental (pentoxifylline) belongs to the class of medications used for blood flow and is commonly considered by clinicians evaluating treatment options for this condition. Patients looking closely at trental for lymphedema will find that the medication offers a practical option for many individuals dealing with this specific issue, particularly when first-line approaches have provided incomplete relief. As with any prescription or over-the-counter medication, proper dosing and adherence to usage guidelines are essential to getting the most benefit from Trental while minimizing the risk of side effects. Taking the medication as directed, at the appropriate time of day, and for the full recommended duration helps ensure therapeutic blood levels are maintained. Patients should inform their healthcare provider of all other medications they are taking to check for potential interactions. For broader context on treatment options related to blood flow, blood flow provides evidence-based information covering the full range of medications used in this therapeutic area, helping patients and caregivers compare approaches and make informed decisions alongside their medical team.